1150100-37-0Relevant academic research and scientific papers
CCR5 ANTAGONISTS AS THERAPEUTIC AGENTS
-
Page/Page column 29-30, (2009/07/17)
The present invention relates to compounds useful in the treatment of CCR5-related diseases and disorders, for example, useful in the inhibition of HIV replication, the prevention or treatment of an HIV infection, and in the treatment of the resulting acq
CCR5 ANTAGONISTS AS THERAPEUTIC AGENTS
-
Page/Page column 19-20, (2009/06/27)
The present invention relates to compounds useful in the treatment of CCR5-related diseases and disorders, for example, useful in the inhibition of HIV replication, the prevention or treatment of an HIV infection, and in the treatment of the resulting acq
CCR5 ANTAGONISTS AS THERAPEUTIC AGENTS
-
Page/Page column 22, (2009/06/27)
The present invention relates to compounds useful in the treatment of CCR5-related diseases and disorders, for example, useful in the inhibition of HIV replication, the prevention or treatment of an HIV infection, and in the treatment of the resulting acquired immune deficiency syndrome (AIDS).
